Scythian Biosciences Corporation



Smart Employee Benefits Inc.
Latest Comments
image_pdfimage_print

Patent pending cannabinoid compounds bring new treatments to market


November 14, 2017
| November 14, 2017

Cannabinoids, the diverse compounds which bind to the homonymous receptors in the human body, are only recently being properly explored, […]


 

Scythian CEO on the potential impact of cannabinoid drugs on traumatic brain injuries


August 29, 2017
| August 29, 2017 | 1 Comment

Jonathan Gilbert, CEO and Director, and David Schrader, COO of Scythian Biosciences Corp. (TSXV: SCYB) (“Scythian”) in an interview with […]


Scythian to treat the secondary effects of traumatic brain injuries with cannabinoids


August 14, 2017
| August 14, 2017 | 3 Comments

Scythian BioSciences Corp. (TSXV: SCYB), which began trading on the TSXV last week under the symbol SCYB, is developing cannabinoid-based drugs to […]


Matamec Explorations Inc.